XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT03745053
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Registry
-
NCT03745053
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy, Spain
- Registry status
- Completed
Technical summary
Registry record NCT03745053. Randomized; single masking; primary purpose treatment. Start 2019-02-05 (actual); primary completion 2023-09-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization
- Acronym
- XLIMIT
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Xlimus DES Implantation during coronary angioplasty
- Intervention (Device)
- Synergy DES Implantation during coronary angioplasty
- Lead sponsor
- Cardionovum GmbH
- Collaborator
- Mediolanum Cardio Research
Record details
- Record id
cardio:ct-nct03745053- Content hash
7753bf7084c717af11ec83ff4eed4385b7651e61a5046e50406c706539345224